Daxor Debt to Equity Ratio 2010-2011 | DXR
Current and historical debt to equity ratio values for Daxor (DXR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Daxor debt/equity for the three months ending December 31, 2011 was 0.00.
Daxor Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2011-12-31 |
$0.05B |
$0.04B |
1.37 |
2011-09-30 |
$0.05B |
$0.04B |
1.35 |
2011-06-30 |
$0.05B |
$0.05B |
1.11 |
2011-03-31 |
$0.05B |
$0.05B |
1.01 |
2010-12-31 |
$0.04B |
$0.05B |
0.94 |
2010-09-30 |
$0.04B |
$0.05B |
0.79 |
2010-06-30 |
$0.04B |
$0.04B |
0.86 |
2010-03-31 |
$0.04B |
$0.05B |
0.87 |
2009-12-31 |
$0.03B |
$0.05B |
0.58 |
2009-09-30 |
$0.03B |
$0.05B |
0.58 |
2009-06-30 |
$0.03B |
$0.05B |
0.66 |
2009-03-31 |
$0.03B |
$0.03B |
0.95 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-OUTP/HM CRE |
$0.036B |
$0.000B |
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
|